计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| C102301-1g |
1g |
现货 ![]() |
| |
| C102301-5g |
5g |
现货 ![]() |
| |
| C102301-25g |
25g |
现货 ![]() |
| |
| C102301-100g |
100g |
现货 ![]() |
| |
| C102301-500g |
500g |
现货 ![]() |
|
| 别名 | 西咪替丁 | 2-氰基-1-甲基-3-[2-(5-甲基-1H-咪唑l-4-基-甲硫基)乙基]胍 | 甲氰咪胍 | 甲氰咪胺 |
|---|---|
| 英文别名 | 1-Cyano-2-methyl-3-(2-(((5-methyl-4-imidazolyl)methyl)thio)ethyl)guanidine | Aciloc | CIMETIDINE A | Ulcimet | Cimetag | Cimetidinum | FPF 1002 | Tagamet | Brumetidina | CIMETIDINE [USP MONOGRAPH] | Edalene | SKF 92334 | Tocris-0902 | Ulcedin | 2-Cyano-1- |
| 规格或纯度 | Moligand™, ≥99% |
| 英文名称 | Cimetidine |
| 生化机理 | H2 组胺受体拮抗剂;I1咪唑啉受体激动剂;抗溃疡剂。通过抑制内皮细胞表面 E 选择素的表达,从而阻断肿瘤细胞的粘附,阻止癌症转移。也是一种 I 1 受体激动剂。具有抗肿瘤和免疫调节活性。 |
| 应用 | H2的组胺受体拮抗剂; I1咪唑啉受体激动剂;抗溃疡剂。通过抑制电子的内皮细胞表面选择素的表达,阻止癌细胞转移,从而阻断肿瘤细胞的粘附。 |
| 储存温度 | 2-8°C储存 |
| 运输条件 | 冰袋运输 |
| 作用类型 | 抑制剂 |
| 作用机制 | 组胺 H2 受体拮抗剂 |
| 备注 | 如果有可能,您尽量在使用的当天配置溶液,并在当天使用完它。但是,如果您需要预先配制储备溶液,我们建议您将溶液等份保存在-20°C的密封小瓶中。通常,它们最多可以使用一个月。在使用前和打开样品瓶之前,我们建议您让您的产品在室温下平衡至少1小时。需要更多关于溶解度,用法和处理的建议吗?请访问我们的常见问题(FAQ)页面以获取更多详细信息。 |
| 产品介绍 |
H2的组胺受体拮抗剂; I1咪唑啉受体激动剂;抗溃疡剂。通过抑制电子的内皮细胞表面选择素的表达,阻止癌细胞转移,从而阻断肿瘤细胞的粘附。 |
| 纯度 | ≥99% |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| PubChem SID | 504750600 |
|---|---|
| EC号 | 257-232-2 |
| 分子类型 | 小分子 |
| IIUPAC Name | 1-cyano-2-methyl-3-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]guanidine |
| INCHI | 1S/C10H16N6S/c1-8-9(16-7-15-8)5-17-4-3-13-10(12-2)14-6-11/h7H,3-5H2,1-2H3,(H,15,16)(H2,12,13,14) |
| InChi Key | AQIXAKUUQRKLND-UHFFFAOYSA-N |
| Smiles | CC1=C(N=CN1)CSCCNC(=NC)NC#N |
| Isomeric SMILES | CC1=C(N=CN1)CSCCNC(=NC)NC#N |
| 分子量 | 252.34 |
| Reaxy-Rn | 807826 |
| Reaxys-RN link address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=807826&ln= |
| 溶解性 | Soluble to 50 mM in water and to 100 mM in DMSO, solubility in HCl (almost transparency). |
|---|---|
| 密度 | 1.27 |
| 熔点 | 141°C |
| 分子量 | 252.340 g/mol |
| XLogP3 | 0.400 |
| 氢键供体数Hydrogen Bond Donor Count | 3 |
| 氢键受体数Hydrogen Bond Acceptor Count | 4 |
| 可旋转键计数Rotatable Bond Count | 7 |
| 精确质量Exact Mass | 252.116 Da |
| 单同位素质量Monoisotopic Mass | 252.116 Da |
| 拓扑极表面积Topological Polar Surface Area | 114.000 Ų |
| 重原子数Heavy Atom Count | 17 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 296.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
| 象形图 | GHS05, GHS08 |
|---|---|
| 信号词 | 危险 |
| 危险声明 |
H318: 造成严重的眼睛损伤 H360: 可能损害生育力或未出生的孩子 H373: 通过长时间或反复暴露对器官造成损害 |
| 预防措施声明 |
P260: 不要吸入灰尘/烟雾/气体/雾/蒸汽/喷雾。 P280: 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。 P405: 密闭存放 P501: 将内容物/容器处理到。。。 P203: 使用前,获取、阅读并遵守所有安全说明。 P264+P265: 处理后彻底洗手[和…]。不要触摸眼睛。 P305+P354+P338: 如果进入眼睛:立即用水冲洗几分钟。取下隐形眼镜(如果有的话),并且操作简单。继续冲洗。 P318: 如果暴露或担心,请就医。 P317: 寻求紧急医疗救助。 P319: 如果你感到不适,请寻求医疗帮助。 |
| WGK Germany | 3 |
| RTECS | MF0035500 |
| Merck Index | 2279 |
| 个人防护装备 | Eyeshields,full-face particle respirator type N100 (US),Gloves,respirator cartridge type N100 (US),type P1 (EN143) respirator filter,type P3 (EN 143) respirator cartridges |
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
| 批号(Lot Number) | 证书类型 | 货号 |
|---|---|---|
| 分析证书 | C102301 | |
| 分析证书 | C102301 | |
| 分析证书 | C102301 | |
| 分析证书 | C102301 | |
| 分析证书 | C102301 | |
| 分析证书 | C102301 | |
| 分析证书 | C102301 | |
| 分析证书 | C102301 | |
| 分析证书 | C102301 | |
| 分析证书 | C102301 | |
| 分析证书 | C102301 | |
| 分析证书 | C102301 | |
| 分析证书 | C102301 | |
| 分析证书 | C102301 | |
| 分析证书 | C102301 | |
| 分析证书 | C102301 | |
| 分析证书 | C102301 |
¥338.32
| 1. Lu Zhao, Jie Liu, Yunfeng Bai, Feng Feng, Xiaoming Yang. (2021) Exploration of carbon dots derived from epimedium towards detecting dopamine and hydrogen peroxide. COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS, 627 (127179). [10.1016/j.colsurfa.2021.127179] |
| 2. Renjie Xu, Hongdan Zhu, Lingmin Hu, Beimeng Yu, Xiaohua Zhan, Yichu Yuan, Ping Zhou. (2020) Characterization of the intestinal absorption of morroniside from Cornus officinalis Sieb. et Zucc via a Caco-2 cell monolayer model. PLoS One, 15 (5): (e0227844). [PMID:32470043] [10.1371/journal.pone.0227844] |
| 3. Lisha Jin, Sisi Zhou, Shujie Zhu, Shaowei Lei, Weijuan Du, Huidi Jiang, Su Zeng, Hui Zhou. (2019) Dehydrocorydaline induced antidepressant-like effect in a chronic unpredictable mild stress mouse model via inhibiting uptake-2 monoamine transporters. EUROPEAN JOURNAL OF PHARMACOLOGY, 864 (172725). [PMID:31604070] [10.1016/j.ejphar.2019.172725] |
| 4. Qingquan Zeng, Mengru Bai, Cui Li, Shuanghui Lu, Zhiyuan Ma, Yunchun Zhao, Hui Zhou, Huidi Jiang, Dongli Sun, Caihong Zheng. (2019) Multiple Drug Transporters Contribute to the Placental Transfer of Emtricitabine. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, [PMID:31160284] [10.1128/AAC.00199-19] |
| 5. Yufeng Chen, Fan Xue, Guobin Xia, Zhenlei Zhao, Chun Chen, Yunhong Li, Ying Zhang. (2019) Transepithelial transport mechanisms of 7,8-dihydroxyflavone, a small molecular TrkB receptor agonist, in human intestinal Caco-2 cells. Food & Function, 10 (8): (5215-5227). [PMID:31384856] [10.1039/C9FO01007F] |
| 6. Renjie Xu, Yichu Yuan, Jia Qi, Jia Zhou, Xiaowen Guo, Jian Zhang, Ruanjuan Zhan. (2018) Elucidation of the Intestinal Absorption Mechanism of Loganin in the Human Intestinal Caco-2 Cell Model. Evidence-based Complementary and Alternative Medicine, 2018 (8340563). [PMID:30671130] [10.1155/2018/8340563] |
| 7. Xu Renjie, Peng Ying, Wang Mengyue, Li Xiaobo. (2019) Intestinal Absorption of Isoalantolactone and Alantolactone, Two Sesquiterpene Lactones from Radix Inulae, Using Caco-2 Cells. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 44 (2): (295-303). [PMID:30209793] [10.1007/s13318-018-0510-x] |
| 8. Li Wang, Yan Sun, Qi Liu. (2015) Determination of Pharmaceuticals and Personal Care Product Components in Wastewater Using Capillary Electrophoresis Coupled with Solid Phase Extraction. ANALYTICAL LETTERS, [10.1080/00032719.2014.966377] |
| 9. Guodong Shan, Xiuqin Fan, Qingcheng Wang, Li Zhang, Lijun Ge, Weibo Lu, Jing Xue, Kang Chen, Zejun Wang, Qing Shen. (2025) Development of a Captiva EMR-lipid clean-up and LC-MS/MS methodology for detecting H2 receptor antagonists in functional foods and food-medicine homology materials. Applied Food Research, 5 (100772). [10.1016/j.afres.2025.100772] |